Smiths Detection and Novartis Diagnostics have entered an collaboration and license agreement for marketing the Bio-Seeq instrument. This uses LATE PCR technology developed in the Wangh lab at Brandeis and licensed by Smiths Detection.
Smiths Detection and Novartis Diagnosics sign deal for LATE PCR technology
March 25, 2010 By
